| |
|
|
|
Kintara Therapeutics Inc.  
|
|
1.31 0.01 (0.01%) |
09-21 10:37 |
|
Open: |
1.32 |
Pre close: |
1.3 |
Target:
|
1.71
|
|
High: |
1.3654 |
Low: |
1.3057 |
Resistance:
|
1.46
1.59
|
|
Volume: |
39,412 |
Market Cap: |
43M |
Support:
|
1.25
1.04
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.34
 |
MACD |
MACD(12,26):
|
-0.06 |
|
MA(20): |
1.44 |
Signal(12,26,9): |
-0.05 |
|
MA(100): |
1.61 |
Stochastic Oscillator |
%K(14,3):
|
28.56  |
|
MA(250): |
1.64 |
%D(3): |
28.47 |
|
Average Volume(K) |
3-Month: |
600533
|
52-Week |
High:
|
3.35 |
|
10-Days: |
24013 |
Low: |
1.18 |
|
RSI |
RSI(14):
|
39.36 |
Change(%): |
8.2 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-356.8 |
Shares Out. (M) |
32.62 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-92.1 |
Shares Float (M) |
28.97 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.04 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
8.39 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1280 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-16.75 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.46 |
P/CF |
-2.61 |
|
|
|
|
|
|
